ERN EuroBloodNet
erneurobloodnet.bsky.social
ERN-EuroBloodNet aims to improve healthcare and quality of life of patients with Rare Hematological Diseases. Funded by the European Union.
👤 Joined on 09 May 2025
59
Followers
75
Following
53
Total Posts
📜 Kullanıcı Geçmişi
- 09 May 2025, 14:06
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@erneurobloodnet.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
Artificial intelligence is already being applied in rare haematological diseases. The #SYNTHEMA and @erneurobloodnet.bsky.social training programme, led by experts from the field, covers synthetic data, federated learning, regulation and clinical use cases. Register: synthema.eu/training/
Show PostHow will synthetic data be applied in real research? This final session will present use cases in Sickle Cell Disease and Acute Myeloid Leukaemia as part of the joint #SYNTHEMA and @erneurobloodnet.bsky.social training programme. 👉 Register: synthema.eu/training/
Show Post
Sustaining cancer Networks of Expertise goes beyond project funding. They require structure, operational capacity and long-term support. In JANE-2, this is addressed through the Work Package on Sustainability (WP4). #JANE2 #EUnetCCC #EU4Health #CancerCare #HaDEA
Show Post#AML is the most common acute leukemia in adults – fast-progressing but treatable. In SYNTHEMA’s Use Case 1, AI creates synthetic data from 2,500+ AML patients to predict survival & treatment responses, while protecting privacy. 👉Learn more about our approach: synthema.eu
Show PostJoin the first #SYNTHEMA webinar in our training series! 8 May 2026 | 12:30 CEST Explore the @erneurobloodnet.bsky.social infrastructure for synthetic data: governance, strategy & architecture. Open to patients & health professionals. 👉 synthema.eu/training/ Don’t miss it & share!
Show Post